Life Sciences
A Fresh Look at Medical Device Maker DexCom After Earnings
The shares gapped higher Friday to refresh the uptrend.
Struggling 3M Needs to Form a Base, but Lowered Guidance Won't Help
The diversified technology giant has been bearish for months and is likely to remain so after reducing its full-year revenue and profit forecasts.
Bearish Bets: 3 Stocks You Should Think About Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
Harmony Biosciences Could Soon Sing an Uplifting Tune
Here's our trading strategy for the shares.
My Chart Intel Says to Shy Away From Intellia Therapeutics
The technical signals of the genome editing company are largely bearish and indicate its stock is poised to weaken.
We're Changing Our DexCom Strategy as the Shares Move Higher
Here's what traders should do now.
Edwards Lifesciences Sends Positive Signals but Merits Wait-and-See Approach
The charts of the producer of medical technology show promise but could be derailed by weakness in the broader markets.
I've Got a Rough Floorplan for How to Play Blueprint Medicines
The charts for this drug developer are starting to take shape.
Edwards Lifesciences Offers Promise for Patients and Investors
Traders have been shifting from aggressive selling to aggressive buying.
This Won't Hurt a Bit: Moderna Could Rally 25% From Here
The stock is ready to make a recovery rally.